Re:Problems Found at Theranos Lab
by hkmurakami on Monday January 25, 2016 @05:27AM
(#10966447)
Friend recently told me that when Theranos first hit the news as a darling startup, his MIT Microfluidics PhD friends went to see what the novel science was about. Naturally they read her paper and ... They couldn't find anything new/special in the paper and were left scratching their heads.
Maybe VC stronger connections with scientists, not just technologies when doing due diligence?
By the way this is a non sequitur but I find it poetically ironic that Theranos HQ is located on Page Mill Road where WSJ's Silicon Valley branch used to be located back in the day.
Re:Problems Found at Theranos Lab
by madaxe_again on Monday January 25, 2016 @06:32AM
(#10966600)
I've been maintaining for a while that Theranos is a very cynical investment vehicle, and has little to do with medicine. The backgrounds of those connected, of her family, of the trajectory and direction of the company (everything has been very PR and financial press oriented) suggests that their key mission is to grow the value of the company, rather than do anything novel.
The sad thing is, this seems to be an increasingly common strategy in a certain segment of the business world, and it brings value to nobody ultimately - it just separates optimistic investors who just see a wunderkind and incredible new technology from their money.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @12:51PM
(#10968635)
> Very few of us actually give a shit about doing something novel.
Most novelty presents outside of business in general, including startups. Startups generally are applying the novelty (that is no longer novel) that is perceived as potentially valuable to see if it actually is.
Ideally, startups should be focused on doing something _well_, rather than doing something _novel_. To the extent that novelty occurs, it should be a side effect of that objective.
Re:Problems Found at Theranos Lab
by AndrewKemendo on Monday January 25, 2016 @01:04PM
(#10968718)
I think the whole ethos behind a high-tech startup is that you do something well by implementing a novel (in the sense of adoption rate) process or technology.
There is certainly room for disagreement, but all of the "high tech startups" that make up the startup zeitgeist, were exactly that.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:21PM
(#10968826)
> I think the whole ethos behind a high-tech startup is that you do something well by implementing a novel (in the sense of adoption rate) process or technology.
That might be the ethos, but it isn't the reality. Most startups aren't first movers, and most of the ones who succeed aren't either.
Throwing in "in the sense of adoption rate" is kind of silly though, no? Every mom & pop shop has its own unique process that hasn't been widely adopted.
I swear, those Zappos shoes are just like the ones you get on other web sites.
Re:Problems Found at Theranos Lab
by AndrewKemendo on Monday January 25, 2016 @01:34PM
(#10968917)
Most startups aren't first movers
I'm not talking about those, and it's not even necessary to be a first mover so long as the startup is overhauling how things get done outside of the current dominant market leader.
I'm talking about Microsoft, Uber, Amazon etc... the ones who have literally changed the way people live.
Those are the ones that actually held up the ethos.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:56PM
(#10969082)
> I'm talking about Microsoft, Uber, Amazon etc... the ones who have literally changed the way people live.
...or they road a wave...
You didn't mention Walmart. ;-)
Uber has had a number of competitors, back in their day when they were "changing the world", so did Microsoft & Amazon. Hell, Microsoft's operating system ride started with an operating system they bought from someone else.
If you grow at a crazy fast rate to become a household name, you inherently are riding some kind of wave change. I don't think that was what the MIT Microfluidics PhD friend was referring to as "novel". If you want to call that "novel", then you are going to have a much harder time making the case that Theranos isn't trying to be novel.
Re:Problems Found at Theranos Lab
by AndrewKemendo on Tuesday January 26, 2016 @01:15AM
(#10972096)
You didn't mention Walmart. ;-)
Well they are the ones being disrupted currently. They did it in the 80s and 90s to Sears and the rest.
you are going to have a much harder time making the case that Theranos isn't trying to be novel.
I actually think Theranos is trying to be novel, my initial response was that maximizing value isn't something new in the valley. I have no clue on whether they are or not in reality, but they portray themselves as actually making new technology - my guess is that they just can't do it and are trying to buy time.
Re:Problems Found at Theranos Lab
by jhanschoo on Tuesday January 26, 2016 @04:53AM
(#10972639)
It's not exactly true that startups that have no desire to innovate provide a negative or zero value to their industry. In competitive strategy, a small company that threatens to take a slice of the market of a large monopolistic company is good persuation for the monopolistic company to innovate.
Re:Problems Found at Theranos Lab
by danieltillett on Monday January 25, 2016 @09:34AM
(#10967334)
While I am not going to question your cynicism, it would appear the aim was more to exploit the USA military not do a standard pump and dump. Look at the board.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @12:46PM
(#10968605)
> their key mission is to grow the value of the company, rather than do anything novel.
Well, from an investor's perspective, doing anything novel is fraught with risk, and growing the value of the company is what feeds my ROI. If there is a way to grow the value without taking that risk, they ought to do it. Be novel only when necessary.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:50PM
(#10969036)
Of course not everything is about ROI. However, the VC model is predicated on outsized returns. Without that they don't exist. Novelty's value to a VC is that it makes it more credible that they'll see such outsized returns.
When founding a new organization, you have a choice of making it for-profit, or non-profit. If you choose for-profit, you are making a statement about your priorities; when you take VC money, the term sheets are very clear about the ambitious ROI you are going for.
Re:Problems Found at Theranos Lab
by AndrewKemendo on Tuesday January 26, 2016 @01:17AM
(#10972108)
I think your point about profit vs non-profit is a good one.
Unfortunately I have yet to see a non-profit or FOSS bring widespread changes to the way people live and work - so we are kind of stuck for a while with this model eh?
Re:Problems Found at Theranos Lab
by jhonovich on Sunday January 24, 2016 @09:04PM
(#10965179)
"UCSF charges Theranos more than $300 for a comprehensive metabolic panel, said a person familiar with the matter. Theranos’s website shows that patients who get the same test at one of the company’s blood-draw sites pay just $7.19. A comparison of all the tests done by UCSF for Theranos shows that the company appears to be incurring losses on many of those tests."
If correct, anyone have a legitimate rationale for Theranos doing this?
Re:Problems Found at Theranos Lab
by nradov on Monday January 25, 2016 @01:35AM
(#10965924)
In order to compete against LabCorp and Quest Diagnostics, Theranos needs to offer a full range of lab tests. If they are still scaling up then it might make sense to outsource some tests even if they lose money doing it in order to build market share and test out their processes. And then they can gradually start doing more and more of those tests in house in order to bring costs down. (But I have no idea what's going on in Theranos or if they have legitimate reasons.)
Re:Problems Found at Theranos Lab
by mnglkhn2 on Monday January 25, 2016 @08:02AM
(#10966913)
UCSF does not operate at the scale LabCorp and Quest do and hence cannot benefit from economies of scale.
Also, Theranos might not have the option to outsource to one of the big two, and hence operates with the smaller entity, which charges them a "special" fee, given the "special" situation.
In other words: it is a price dictated by business decisions and not based on economics.
PS: The WSJ article is more of an effort by Walgreens to do damage control and try to distance themselves from Theranos.
Most likely their brand took a hit from this association.
(also, it looks like Walgreens loaned Theranos $50mil for this deal)
Re:Problems Found at Theranos Lab
by CamperBob2 on Monday January 25, 2016 @06:39AM
(#10966626)
"The tests are performed on machines based on the AutoAnalyzer invented in 1957."
That's like saying that modern PCs are based on the IBM 360 architecture from 1964. To the extent it's true, it's true in a way that makes sense only to a tech-illiterate journalist.
Re:Problems Found at Theranos Lab
by danso on Monday January 25, 2016 @07:17PM
(#10971065)
No argument there...just wanted to point out that the author of the submitted article didn't make such a claim, as that would cast some doubt about the assertions of the reporting.
Re:Problems Found at Theranos Lab
by rdlecler1 on Monday January 25, 2016 @08:06AM
(#10966926)
Theranos operates under the explicit assumption blood Is homogeneous for a large number of markers and that any two nanotainer sized samples will be identical. If they are not, then in principle nanotainers can not work because the sample size is too small.
Re:Problems Found at Theranos Lab
by drcode on Monday January 25, 2016 @09:42AM
(#10967379)
> If they are not, then in principle nanotainers can not work because the sample size is too small.
I am the last person who wants to defend Theranos, but theoretically if there are only a finite number of ways for tissue contaminants to enter a sample, these contaminants could be corrected for with statistical methods and accurate results could still be possible.
Re:Problems Found at Theranos Lab
by mbreese on Monday January 25, 2016 @09:50AM
(#10967433)
You can't correct for inadequate sample sizes with statistics and still expect a clinically relevant result (the confidence interval would be too large). The issue isn't contamination in small samples, it's that the biomarkers they need to measure may not be accurately measurable at such small volumes - in particular with the value ranges required for the test.
It may just be that their "nanotainer" tests may only be viable for boolean tests like their herpes test (herpes DNA present - yes / no).
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @12:53PM
(#10968651)
Wait, what?
How do you statistically compensate for a sample size of one, or zero?
The issue here isn't contaminants in the sample, it's the markers (i.e., what is being tested for) in the sample. If marker isn't uniformly distributed, then these small samples might not even find it in them.
Re:Problems Found at Theranos Lab
by randycupertino on Monday January 25, 2016 @05:16AM
(#10966420)
I am just so amazed Theranos was able to raise so much $$ on basically a wink and a smile without and due diligence by the investors. Everyone was distracted by the blonde blue eyed Stanford dropout in the Steve Jobs outfit! And now Theranos is blowing through investors $$ outsourcing their tests to UCSF because their tech has failed. Hope WSJ keeps kicking the tires on this.
Re:Problems Found at Theranos Lab
by joezydeco on Monday January 25, 2016 @10:16AM
(#10967581)
Let's also not underestimate the insanely powerful board of directors that was assembled.
You have a handful of US Senators, a couple of CEOs from megacompanies like Bechtel and Wells-Fargo, the ex-director of the CDC, and two ex-Secretaries of State including Henry Kissinger.
How many other 19 year-old college dropouts can put that board together?
Re:Problems Found at Theranos Lab
by joezydeco on Monday January 25, 2016 @11:50AM
(#10968218)
Launching a new medical device is hard. You have multiple walls to scale including the FDA, the insurance companies, Medicare, and the providers themselves (hospitals, doctors, labs, storefronts, etc).
Having this group in place seemed to send the message of "don't worry, we'll just tunnel through those hurdles" when it came to all the red tape.
Re:Problems Found at Theranos Lab
by pron on Monday January 25, 2016 @05:46AM
(#10966497)
While I agree with the essence of your comment, there is no need (and no justification) to draw attention to Theranos's founder's looks. Investors are often swayed to invest unbelievable amounts of money in various convincing charmers (and Holmes is definitely impressive in that way) who sell them a dream -- see Shai Agassi at Better Place[1] and others. I see no reason to believe that Holmes's blonde hair and blue eyes played any role here, at least not any more than Agassi's square jaw. As I don't recall Agassi's jaw being mentioned as a contributing factor in the exorbitant investments he received, mentioning it in Holmes's case feels a little off.
Re:Problems Found at Theranos Lab
by 55555 on Monday January 25, 2016 @06:26AM
(#10966585)
> there is no need (and no justification) to draw attention to Theranos's founder's looks.
When there's a possibility that she dresses in a certain way in order to subconsciously convince people that she's a maverick visionary, or when she lacks that intent but it probably had that effect, I think it's justified (but not needed). And a defined masculine jaw would probably help you raise money, just like it helps you get dates.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:04PM
(#10968725)
> When there's a possibility that she dresses in a certain way in order to subconsciously convince people that she's a maverick visionary, or when she lacks that intent but it probably had that effect, I think it's justified (but not needed). And a defined masculine jaw would probably help you raise money, just like it helps you get dates.
Appearance no doubt helps. The notion that it is a significant enough factor to be worth mentioning here doesn't appear to be borne out in the allocation of VC funds.
Re:Problems Found at Theranos Lab
by pron on Monday January 25, 2016 @07:36AM
(#10966816)
> When there's a possibility that she dresses in a certain way
Obviously I wasn't referring to the clause about her attire.
> And a defined masculine jaw would probably help you raise money
Absolutely, but that was not my point. The point is that if the matter of appearance is commonly brought up when a woman is involved but rarely when a man is, then there's a problem. If the matter of Agassi's jaw had been brought up as a likely reason for his ability to fool (or not) investors as often as Holmes's natural physical appearance comes up, I wouldn't have said a thing.
I'm not objecting at all to the likely hypothesis (perhaps a well-supported theory by now) that physical appearance matters a lot in all sorts of circumstances, but to the tendency to bring up physical appearance as a significant cause for success only (or almost only) when discussing women, and when the actual amount information supporting this hypothesis in both cases (of men and women) is similarly nonexistent (and possibly similarly likely in both cases).
Re:Problems Found at Theranos Lab
by adwn on Monday January 25, 2016 @08:17AM
(#10966972)
In this case, her gender and her looks are actually relevant, since most VCs are male, and it would be naive to assume that VCs are completely immune to the influence of a young, attractive woman.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:44PM
(#10968998)
There is data on this everywhere. It'd be hard to miss if you looked at even a handful of funding rounds (though the industry is getting better at this). Clarity came up at the top of the Google search: http://blog.clarity.fm/why-women-founders-matter/
It shows 4-9% of VC funding goes to companies with female founders, roughly tracking the percentage of women at top VC firms.
People need evidence to accept this blatant reality of the tech scene, but making assertions about young, attractive women being blindly handed billions of dollars...
Re:Problems Found at Theranos Lab
by pron on Monday January 25, 2016 @08:24AM
(#10967004)
So what you're saying is that SV's well-documented sexism is (among many other things, also) may also be a significant contributing factor for reckless investment. But in this case, I don't see the problem. If in 9 cases out of 10 women get the short end of the stick due to sexism, that some of them are occasionally able to turn the tables and use it for their own advantage is nothing but a cause for celebration: "Ingenious Woman Turns Investors' Harmful Sexism Against Them". Social hacking at its best!
If women were only truly able to pull-off "a Holmes" (i.e., con male investors out of their money using their sexual charms), maybe that threat would finally get investors to start seeing sexism as a serious problem.
The only thing that's bugging me about your solution to sexism, is that according to that logic, women should be at a great advantage when raising money from VCs (unless you also claim that their natural lack of cunning offsets that advantage), yet in practice we see the exact opposite. So it's unclear to me how -- without any other information on investors' reasoning -- femininity could be at all mentioned as an advantage when fundraising, while data shows it to be otherwise.
Re:Problems Found at Theranos Lab
by adwn on Monday January 25, 2016 @09:03AM
(#10967177)
> So what you're saying is that SV's well-documented sexism is (among many other things, also) may also be a significant contributing factor for reckless investment.
No, I'm not saying that at all, and my point was completely unrelated to sexism. You can be entirely un-sexist and still be subconsciously influenced by the attractiveness of the opposite sex (in case of heterosexuality; applies correspondingly to homosexual people). It's a natural bias which we should be aware of and recognize in ourselves, so that we can compensate for it.
My point was that the majority of SV's VCs are male (and presumably mostly heterosexual, like the rest of the population), so it is plausible that Holmes' gender and looks influenced VC decisions to a certain degree.
Re:Problems Found at Theranos Lab
by 50CNT on Monday January 25, 2016 @09:32AM
(#10967321)
Wouldn't the outcome that they just start investing less in women due to (subconscious) group association be just as likely? After all, if you're getting investment through your belonging in a certain group, and then never deliver, you're muddying the waters for other members of your group, whether that be expats, women, young founders, old founders, etc.
Even though I'm all for using your weaknesses as strengths,
getting back what's owed to you, etc, I'm seriously doubtful that "pullin'a 'olmes" is a cause for celebration. If anything, it tarnishes the image of female founders in the long term, and at best its short sighted revenge. There's a lot more good to be had if there were female founders publicly pulling a Zuckerberg or a Gates, and I'm sure there will be.
Re:Problems Found at Theranos Lab
by pron on Monday January 25, 2016 @10:09AM
(#10967543)
I was being sarcastic. Clearly the data show that not only do women not have a better chance at getting investment, they have a worse chance, in spite of their supposed irresistible charm and the fact that they are less likely to be swindlers. Which is why I find it funny that not only do looks get mentioned only when women are concerned, they are mentioned as an obvious advantage while women are empirically at a disadvantage when it comes to convincing investors.
If you read testimonials of female entrepreneurs online you will see that while investors' attraction towards them may manifest itself in several ways, increased chance of investment is generally not one of them.
Re:Problems Found at Theranos Lab
by 50CNT on Monday January 25, 2016 @02:19PM
(#10969228)
I've heard the stories of investors hitting on female founders, and they're just as disturbing to me as they are to you. Unsurprising, but still incredibly unprofessional.
Though I'm also unsurprised that looks are mentioned about when males talk about female founders. I don't think it's meant maliciously, it's an error of habit. There's probably a purpose built part of my brain just of evaluating womens looks, and that bubbles up. But calling it out seems appropriate, it has little to do with the discussion.
But investors investing less into female founders despite them being less likely to be swindlers/more likely to be better founders is a very interesting topic. That goes against their stated purpose, why would they do that?
My personal hunch is that it's that bit of gut feeling that fills in the blanks when metrics run out that is screwing over female founders. When faced with a decision we have insufficient knowledge on, our minds extrapolate from past experience. We look at past events or knowledge that may be applicable, things we've heard, come up with a heuristic answer.
Now the thing is, investors don't know of that many successful female founders, matter of fact, neither do I, at least nowhere close to the number of successful male founders I know of. Those mental queries that would otherwise inspire confidence come up blank, the tally gets taken, and for reasons that don't really matter, the female founder gets short charged.
By the way, this process also works against other social groups and in other situations. Name 10 successful black founders off the top of your head. Chinese-american CEOs (ayy bamboo ceiling). What's your opinion on stay-at-home dads and male nurses? It's insidious, isn't it?
Really, there's only so much we can do against it though. One is being aware of such biases in ourselves and pushing against them, and the other much slower long term solution, adjusting people's mental databases to better reflect modern realities. I guess we need stronger role models for women in technology, ones that do stand against long held beliefs.
After all, female pilots don't seem strange (given Erhard), female programmers don't seem that strange (because of Hopper and other very talented women), female CEOs seem a lot less strange nowadays (example that pops in my mind is Marissa Meyer), but female tech founders still do. But we'll fix that in due time.
Re:Problems Found at Theranos Lab
by DanBC on Monday January 25, 2016 @07:44AM
(#10966846)
> The point is that if the matter of appearance is commonly brought up when a woman is involved but rarely when a man is, then there's a problem.
Yes. And now it's a bit circular: here appearance was heavily commented on when theranos was starting and beginning to raise money; and so now when people write about Theranos they keep mentioning it.
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @01:01PM
(#10968704)
> Everyone was distracted by the blonde blue eyed Stanford dropout in the Steve Jobs outfit!
Please. I'm sure Stanford has an even better looking blond blue eyed dropout every year. If that somehow could get you billions in investment, silicon valley would be filled with founders who looked like pharmaceutical reps.
Re:Problems Found at Theranos Lab
by FullOfGods on Monday January 25, 2016 @07:01AM
(#10966679)
I think the blonde hair and blue eyes have more to do with the witch-hunt by the WSJ than they have had to do with the investors' inclination to invest. There are a million reasons besides failed tech for Theranos to conduct its business the way it is doing right now.
This WSJ article is full of hot air, and actually has nothing of substance to say. The hilarious phrases 'according to people familiar with the matter' and 'a person familiar with the matter' appear nine times in the article, when discussing outcomes that potentially 'could' happen if other things that haven't happened so far actually happened.
But thanks for putting into words what everybody is really thinking, but doesn't want to say out loud. It boggles my mind just how much people really want a pretty girl to fail in the tech business.
Re:Problems Found at Theranos Lab
by TheOtherHobbes on Monday January 25, 2016 @07:20AM
(#10966751)
No one seriously cares what gender Holmes is. At worst her gender is a bit of a novelty, but hardly a USP.
However, they do care that she may be selling snake oil. When someone raises funding on the promise of Amazing Technology[tm], and then fails to deliver that technology in a way that satisfies the usual industry standards, it's a fair concern.
>"according to people familiar with the matter"
This is standard WSJ boilerplate when it uses anonymous sources. There's nothing "hilarious" about it. It's neither unusual nor unfamiliar.
Re:Problems Found at Theranos Lab
by jonknee on Monday January 25, 2016 @09:34AM
(#10967336)
Considering all the other needlessly laudatory press about Theranos you could look at it the other way around and say that the WSJ is not in the tank for Theranos.
Re:Problems Found at Theranos Lab
by ksherlock on Monday January 25, 2016 @09:56AM
(#10967463)
It looks like the little boy has it in for the Emperor's New Clothes. Is there some backstory behind it? Did the Emperor do something to the little boy?
Re:Problems Found at Theranos Lab
by erikpukinskis on Monday January 25, 2016 @11:39AM
(#10968120)
I can't help but shake the feeling some of the bad vibes in this thread, and at Theranos in general, are people excited about seeing a woman CEO fail publicly because it protects the narrative that women are getting undeserved special privileges in today's society. I feel like similar stories of "fake it til you make it" are often valorized here.
Of course I have no reason for believing that. Hopefully I'm wrong. But my spidey sense is tingling. Am I miscalibrated?
Re:Problems Found at Theranos Lab
by cbsmith on Monday January 25, 2016 @12:58PM
(#10968684)
Keep in mind, Theranos had a pretty good PR ride. I think you'd have a hard time making the case that anything that has been constant about the company is a cause of the negative sentiment.
Far more likely is that their is a growing belief that they are not "fake it 'til you make it", but rather just "fake it", and a fear that if left unaddressed, this will harm the ecosystem as a whole.
Maybe VC stronger connections with scientists, not just technologies when doing due diligence?
By the way this is a non sequitur but I find it poetically ironic that Theranos HQ is located on Page Mill Road where WSJ's Silicon Valley branch used to be located back in the day.
The sad thing is, this seems to be an increasingly common strategy in a certain segment of the business world, and it brings value to nobody ultimately - it just separates optimistic investors who just see a wunderkind and incredible new technology from their money.
I propose that this is the majority of startups and an even higher percentage of companies generally.
I even wrote about that distinction last week (https://medium.com/@andrewkemendo/startups-need-to-start-val...) and the response was basically: The only way anything should be evaluated is based on return.
Very few of us actually give a shit about doing something novel.
Most novelty presents outside of business in general, including startups. Startups generally are applying the novelty (that is no longer novel) that is perceived as potentially valuable to see if it actually is.
Ideally, startups should be focused on doing something _well_, rather than doing something _novel_. To the extent that novelty occurs, it should be a side effect of that objective.
There is certainly room for disagreement, but all of the "high tech startups" that make up the startup zeitgeist, were exactly that.
That might be the ethos, but it isn't the reality. Most startups aren't first movers, and most of the ones who succeed aren't either.
Throwing in "in the sense of adoption rate" is kind of silly though, no? Every mom & pop shop has its own unique process that hasn't been widely adopted.
I swear, those Zappos shoes are just like the ones you get on other web sites.
I'm not talking about those, and it's not even necessary to be a first mover so long as the startup is overhauling how things get done outside of the current dominant market leader.
I'm talking about Microsoft, Uber, Amazon etc... the ones who have literally changed the way people live.
Those are the ones that actually held up the ethos.
...or they road a wave...
You didn't mention Walmart. ;-)
Uber has had a number of competitors, back in their day when they were "changing the world", so did Microsoft & Amazon. Hell, Microsoft's operating system ride started with an operating system they bought from someone else.
If you grow at a crazy fast rate to become a household name, you inherently are riding some kind of wave change. I don't think that was what the MIT Microfluidics PhD friend was referring to as "novel". If you want to call that "novel", then you are going to have a much harder time making the case that Theranos isn't trying to be novel.
Well they are the ones being disrupted currently. They did it in the 80s and 90s to Sears and the rest.
you are going to have a much harder time making the case that Theranos isn't trying to be novel.
I actually think Theranos is trying to be novel, my initial response was that maximizing value isn't something new in the valley. I have no clue on whether they are or not in reality, but they portray themselves as actually making new technology - my guess is that they just can't do it and are trying to buy time.
Well, from an investor's perspective, doing anything novel is fraught with risk, and growing the value of the company is what feeds my ROI. If there is a way to grow the value without taking that risk, they ought to do it. Be novel only when necessary.
When founding a new organization, you have a choice of making it for-profit, or non-profit. If you choose for-profit, you are making a statement about your priorities; when you take VC money, the term sheets are very clear about the ambitious ROI you are going for.
Unfortunately I have yet to see a non-profit or FOSS bring widespread changes to the way people live and work - so we are kind of stuck for a while with this model eh?
If correct, anyone have a legitimate rationale for Theranos doing this?
This is what we call a bleeding unicorn.
https://en.m.wikipedia.org/wiki/Comprehensive_metabolic_pane...
"The tests are performed on machines based on the AutoAnalyzer invented in 1957."
Is there some reason that this should cost $300 58 years later? No Moore's Law in medicine?
I suspect that what UCSF is charging Theranos includes a substantial markup on the actual test cost + overhead.
PS: The WSJ article is more of an effort by Walgreens to do damage control and try to distance themselves from Theranos. Most likely their brand took a hit from this association. (also, it looks like Walgreens loaned Theranos $50mil for this deal)
That's like saying that modern PCs are based on the IBM 360 architecture from 1964. To the extent it's true, it's true in a way that makes sense only to a tech-illiterate journalist.
I am the last person who wants to defend Theranos, but theoretically if there are only a finite number of ways for tissue contaminants to enter a sample, these contaminants could be corrected for with statistical methods and accurate results could still be possible.
It may just be that their "nanotainer" tests may only be viable for boolean tests like their herpes test (herpes DNA present - yes / no).
How do you statistically compensate for a sample size of one, or zero?
The issue here isn't contaminants in the sample, it's the markers (i.e., what is being tested for) in the sample. If marker isn't uniformly distributed, then these small samples might not even find it in them.
You have a handful of US Senators, a couple of CEOs from megacompanies like Bechtel and Wells-Fargo, the ex-director of the CDC, and two ex-Secretaries of State including Henry Kissinger.
How many other 19 year-old college dropouts can put that board together?
Having this group in place seemed to send the message of "don't worry, we'll just tunnel through those hurdles" when it came to all the red tape.
[1]: http://www.fastcompany.com/3028159/a-broken-place-better-pla...
When there's a possibility that she dresses in a certain way in order to subconsciously convince people that she's a maverick visionary, or when she lacks that intent but it probably had that effect, I think it's justified (but not needed). And a defined masculine jaw would probably help you raise money, just like it helps you get dates.
Random depressing link: https://www.insidehighered.com/news/2016/01/05/new-study-fin...
Appearance no doubt helps. The notion that it is a significant enough factor to be worth mentioning here doesn't appear to be borne out in the allocation of VC funds.
Obviously I wasn't referring to the clause about her attire.
> And a defined masculine jaw would probably help you raise money
Absolutely, but that was not my point. The point is that if the matter of appearance is commonly brought up when a woman is involved but rarely when a man is, then there's a problem. If the matter of Agassi's jaw had been brought up as a likely reason for his ability to fool (or not) investors as often as Holmes's natural physical appearance comes up, I wouldn't have said a thing.
I'm not objecting at all to the likely hypothesis (perhaps a well-supported theory by now) that physical appearance matters a lot in all sorts of circumstances, but to the tendency to bring up physical appearance as a significant cause for success only (or almost only) when discussing women, and when the actual amount information supporting this hypothesis in both cases (of men and women) is similarly nonexistent (and possibly similarly likely in both cases).
...and it would require completely ignoring the data to think that young, attractive women do well in front of VC's.
There's a real world out there where female founders are fighting to get in the door.
Can you show me this data, so that I can stop ignoring it?
This is a genuine request, I'm not trying to be snarky.
It shows 4-9% of VC funding goes to companies with female founders, roughly tracking the percentage of women at top VC firms.
People need evidence to accept this blatant reality of the tech scene, but making assertions about young, attractive women being blindly handed billions of dollars...
If women were only truly able to pull-off "a Holmes" (i.e., con male investors out of their money using their sexual charms), maybe that threat would finally get investors to start seeing sexism as a serious problem.
The only thing that's bugging me about your solution to sexism, is that according to that logic, women should be at a great advantage when raising money from VCs (unless you also claim that their natural lack of cunning offsets that advantage), yet in practice we see the exact opposite. So it's unclear to me how -- without any other information on investors' reasoning -- femininity could be at all mentioned as an advantage when fundraising, while data shows it to be otherwise.
No, I'm not saying that at all, and my point was completely unrelated to sexism. You can be entirely un-sexist and still be subconsciously influenced by the attractiveness of the opposite sex (in case of heterosexuality; applies correspondingly to homosexual people). It's a natural bias which we should be aware of and recognize in ourselves, so that we can compensate for it.
My point was that the majority of SV's VCs are male (and presumably mostly heterosexual, like the rest of the population), so it is plausible that Holmes' gender and looks influenced VC decisions to a certain degree.
Even though I'm all for using your weaknesses as strengths, getting back what's owed to you, etc, I'm seriously doubtful that "pullin'a 'olmes" is a cause for celebration. If anything, it tarnishes the image of female founders in the long term, and at best its short sighted revenge. There's a lot more good to be had if there were female founders publicly pulling a Zuckerberg or a Gates, and I'm sure there will be.
If you read testimonials of female entrepreneurs online you will see that while investors' attraction towards them may manifest itself in several ways, increased chance of investment is generally not one of them.
Though I'm also unsurprised that looks are mentioned about when males talk about female founders. I don't think it's meant maliciously, it's an error of habit. There's probably a purpose built part of my brain just of evaluating womens looks, and that bubbles up. But calling it out seems appropriate, it has little to do with the discussion.
But investors investing less into female founders despite them being less likely to be swindlers/more likely to be better founders is a very interesting topic. That goes against their stated purpose, why would they do that?
My personal hunch is that it's that bit of gut feeling that fills in the blanks when metrics run out that is screwing over female founders. When faced with a decision we have insufficient knowledge on, our minds extrapolate from past experience. We look at past events or knowledge that may be applicable, things we've heard, come up with a heuristic answer.
Now the thing is, investors don't know of that many successful female founders, matter of fact, neither do I, at least nowhere close to the number of successful male founders I know of. Those mental queries that would otherwise inspire confidence come up blank, the tally gets taken, and for reasons that don't really matter, the female founder gets short charged.
By the way, this process also works against other social groups and in other situations. Name 10 successful black founders off the top of your head. Chinese-american CEOs (ayy bamboo ceiling). What's your opinion on stay-at-home dads and male nurses? It's insidious, isn't it?
Really, there's only so much we can do against it though. One is being aware of such biases in ourselves and pushing against them, and the other much slower long term solution, adjusting people's mental databases to better reflect modern realities. I guess we need stronger role models for women in technology, ones that do stand against long held beliefs.
After all, female pilots don't seem strange (given Erhard), female programmers don't seem that strange (because of Hopper and other very talented women), female CEOs seem a lot less strange nowadays (example that pops in my mind is Marissa Meyer), but female tech founders still do. But we'll fix that in due time.
Yes. And now it's a bit circular: here appearance was heavily commented on when theranos was starting and beginning to raise money; and so now when people write about Theranos they keep mentioning it.
Please. I'm sure Stanford has an even better looking blond blue eyed dropout every year. If that somehow could get you billions in investment, silicon valley would be filled with founders who looked like pharmaceutical reps.
This WSJ article is full of hot air, and actually has nothing of substance to say. The hilarious phrases 'according to people familiar with the matter' and 'a person familiar with the matter' appear nine times in the article, when discussing outcomes that potentially 'could' happen if other things that haven't happened so far actually happened.
But thanks for putting into words what everybody is really thinking, but doesn't want to say out loud. It boggles my mind just how much people really want a pretty girl to fail in the tech business.
However, they do care that she may be selling snake oil. When someone raises funding on the promise of Amazing Technology[tm], and then fails to deliver that technology in a way that satisfies the usual industry standards, it's a fair concern.
>"according to people familiar with the matter"
This is standard WSJ boilerplate when it uses anonymous sources. There's nothing "hilarious" about it. It's neither unusual nor unfamiliar.
We detached this subthread from https://news.ycombinator.com/item?id=10966679 and marked it off-topic.
Of course I have no reason for believing that. Hopefully I'm wrong. But my spidey sense is tingling. Am I miscalibrated?
Far more likely is that their is a growing belief that they are not "fake it 'til you make it", but rather just "fake it", and a fear that if left unaddressed, this will harm the ecosystem as a whole.